Literature DB >> 11275369

Deoxynucleoside anabolic enzyme levels in acute myelocytic leukemia and chronic lymphocytic leukemia cells.

B Jacobsson1, F Albertioni, S Eriksson.   

Abstract

The deoxynucleoside kinase reaction is often rate-limiting in the anabolism of pharmacologically active anti-cancer nucleosides. The levels of thymidine kinase (TK), deoxycytidine kinase, deoxyguanosine kinase (dGK), and thymidylate kinase were determined in leukocyte extracts from patients with chronic lymphocytic leukemia (CLL) and acute myelocytic leukemia (AML). The extracts from AML patients showed significantly higher TK activity than the ones from CLL patients. There were no differences in the levels of the other three kinases. In the case of dGK, the determinations were carried out with both an immunoblotting assay and selective enzyme activity measurements.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275369     DOI: 10.1016/s0304-3835(01)00430-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Kumudha Balakrishnan; Ramadevi Nimmanapalli; Farhad Ravandi; Michael J Keating; Varsha Gandhi
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

2.  Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Dushyant Verma; Susan O'Brien; John Michael Kilpatrick; Yuling Chen; Brenita F Tyler; Susan Bickel; Shanta Bantia; Michael J Keating; Hagop Kantarjian; Varsha Gandhi; Farhad Ravandi
Journal:  Blood       Date:  2010-04-28       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.